Literature DB >> 6829551

Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

A Smedile, C Lavarini, P Farci, S Aricò, G Marinucci, P Dentico, G Giuliani, A Cargnel, C Del Vecchio Blanco, M Rizzetto.   

Abstract

To assess the epidemiology of infection with the delta agent associated with hepatitis B virus, sera from 1314 carriers of the hepatitis B surface antigen (HBsAg) and 687 patients with hepatitis B collected in 1978-1981 from different regions of Italy were tested for delta antigen and antibody to the antigen (anti-delta), and the characteristics of delta-positive patients were analyzed. Anti-delta was found in each center participating in the study, indicating that delta infection has spread throughout Italy. Its prevalence was higher in carriers in southern Italy and in those with chronic hepatitis. In northern Italy, delta infection predominated among southern emigrants in industrial towns but also among parenteral drug addicts with hepatitis B virus infection. The prevalence of delta markers was variable and generally low in acute hepatitis B, suggesting that in Italy self-limited forms of delta infection occur sporadically or by limited outbreaks. Delta infection appears to be endemic in southern Italy but a new epidemiologic event in northern Italy, where it was probably introduced by southern emigrants and is presently exceeding its ethnic confinement to spread selectively in communities of drug addicts. Presumably, the endemicity of delta is maintained by transmission of this agent from carrier to carrier of the HBsAg.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829551     DOI: 10.1093/oxfordjournals.aje.a113533

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

Review 1.  Blood transfusion and hepatitis: still a threat?

Authors:  H W Reesink; C L van der Poel
Journal:  Blut       Date:  1989-01

2.  Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s--a comparison.

Authors:  G Lindh; L Mattsson; M von Sydow; O Weiland
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

3.  Interaction between HDV and HBV infection in HBsAg-chronic carriers.

Authors:  E Sagnelli; F M Felaco; M Rapicetta; T Stroffolini; A Petruzziello; T Annella; P Chionne; G Pasquale; P Filippini; P Peinetti
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

4.  Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India.

Authors:  Shankar Lal Jat; Neha Gupta; Tarun Kumar; Swapnil Mishra; Avani S; Vishwajeet Yadav; Amit Goel; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2015-04-24

5.  Delta-hepatitis.

Authors:  H K Ghuman; S Kaur
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

Review 6.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

7.  Prevalence of antidelta in Turkish children with chronic hepatitis B infection.

Authors:  A Yüce; N Koçak; H Ozen; F Gürakan
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

8.  Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.

Authors:  M De Paschale; M T Manco; L Belvisi; C Magnani; T Re; P Viganò; S Biagiotti; F Capelli; A Mazzone; M P Baldacci; A Ferrara; A L Neri; C M Guastoni; R A Bonazzina; B Brando; P Clerici
Journal:  Infection       Date:  2012-02-25       Impact factor: 3.553

9.  Delta infection in eastern Sicily.

Authors:  A Smedile; M A Freni; L Caruso; A Ajello; C Trischitta; M L Resta; G Bertino; G Berlinghieri; S Rapisarda; L Di Geronimo
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

10.  Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece.

Authors:  A Roumeliotou-Karayannis; N Tassopoulos; E Karpodini; E Trichopoulou; M Kotsianopoulou; G Papaevangelou
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.